First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

of comparison between WATCHMAN FLX and WATCHMAN 2.5 in profiles and

Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)

Diagnostic and Interventional Cardiology

TCT-93 Left Atrial Appendage Sealing Performance of the Amplatzer Amulet and Watchman FLX Device: A Head-to-Head Comparison

Current and Future Strategies for Left Atrial Appendage Closure in Patients With Atrial Fibrillation: Experience at Two Centers

Women may have more adverse events with left atrial appendage occlusion devices than men - Medical Design and Outsourcing

Left atrial appendage occlusion

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

JCM, Free Full-Text

Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device

Transcatheter LAA Closure Transcatheter Left Atrial Appendage Closure